(Q46881097)

26 December 2017

title

The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events (English)

1 reference

26 December 2017

author name string

Hjelmesaeth J

1

1 reference

26 December 2017

Hartmann A

2

1 reference

26 December 2017

Leivestad T

3

1 reference

26 December 2017

Holdaas H

4

1 reference

26 December 2017

Sagedal S

5

1 reference

26 December 2017

Olstad M

6

1 reference

26 December 2017

Jenssen T

7

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

26 December 2017

published in

Kidney International

1 reference

26 December 2017

volume

69

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

588-595

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000116

exact match

0 references

cites work

Diagnosis and classification of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Postprandial hyperglycemia and diabetes complications: is it time to treat?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Insulin resistance and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Ischemic heart disease--major cause of death and graft loss after renal transplantation in Scandinavia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Cardiovascular complications after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Posttransplantation diabetes: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Patient survival after renal transplantation: IV. Impact of post-transplant diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Diabetes mellitus after kidney transplantation in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Incidence and predictors of myocardial infarction after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

C-reactive protein and body mass index independently predict mortality in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

[Improvement of insulin sensitivity after renal transplantation measured by a glucose clamp technique]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Metabolic cardiovascular syndrome after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000116

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000116

1 reference

26 December 2017

1 reference

26 December 2017